Pharmaceutical Technology on MSN10h
AstraZeneca and Alteogen agree on ALT-B4 platform techAstraZeneca has entered an exclusive licence agreement with Alteogen involving the latter’s ALT-B4 platform technology.
Pharmaceutical Technology on MSN8h
Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxiaHealth Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ataxia (FA) in individuals aged 16 years and above.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback